| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
786,383 |
|
|
Indirect Shares
|
362,461 |
|
|
| Direct
Value |
$770,781,161 |
|
|
|
Indirect Value
|
$355,269,774 |
|
|
| Total
Shares |
1,148,844 |
|
|
| Total
Value |
$1,126,050,935 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-16 |
786,383 |
2024-05-16 |
362,461 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-09 |
4 |
OE |
$30.63 |
$7,557,524 |
D/D |
246,736 |
713,990 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO & Pres Regn Res Labs |
• • – |
2010-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
250,000 |
870,375 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CSO |
• • – |
2017-12-18 |
4 |
D |
$386.90 |
$99,762,165 |
D/D |
(257,850) |
422,762 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-07-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
299,134 |
385,954 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-07-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
299,134 |
24,643 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-12-22 |
4 |
D |
$610.04 |
$189,171,574 |
D/D |
(310,097) |
1,019,653 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-11-18 |
4 |
GD |
$0.00 |
$0 |
I/I |
325,986 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-11-18 |
4 |
GA |
$0.00 |
$0 |
D/D |
325,986 |
325,986 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-12-30 |
4 |
OE |
$52.03 |
$20,712,050 |
D/D |
398,079 |
908,303 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-02-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
400,000 |
86,820 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-02-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
400,000 |
400,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-12-22 |
4 |
OE |
$179.13 |
$97,775,813 |
D/D |
442,267 |
1,169,835 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
563,094 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres REGN Res Lab |
• • – |
2012-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
1,333,041 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-07-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
500,000 |
67,976 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-07-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-06-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
500,000 |
253,316 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-06-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
568,343 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
568,343 |
568,343 |
0 |
- |
|
145 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
